Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.

Castellino SM, Geiger AM, Mertens AC, Leisenring WM, Tooze JA, Goodman P, Stovall M, Robison LL, Hudson MM.

Blood. 2011 Feb 10;117(6):1806-16. doi: 10.1182/blood-2010-04-278796. Epub 2010 Oct 29.

2.

Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study.

Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, Robison LL, Mertens AC.

J Clin Oncol. 2009 May 10;27(14):2328-38. doi: 10.1200/JCO.2008.21.1425. Epub 2009 Mar 30. Review.

3.

Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.

Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, Hammond S, Yasui Y, Inskip PD.

J Clin Oncol. 2009 May 10;27(14):2356-62. doi: 10.1200/JCO.2008.21.1920. Epub 2009 Mar 2. Review.

4.

Cause of mortality in 5-year survivors of childhood cancer.

Mertens AC.

Pediatr Blood Cancer. 2007 Jun 15;48(7):723-6. Review.

PMID:
17226844
5.

Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment.

van Leeuwen FE, Ng AK.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):323-330. Review.

PMID:
27913498
6.

Hodgkin lymphoma: Late effects of treatment and guidelines for surveillance.

Ng AK, van Leeuwen FE.

Semin Hematol. 2016 Jul;53(3):209-15. doi: 10.1053/j.seminhematol.2016.05.008. Epub 2016 May 12. Review.

PMID:
27496313
7.

Late complications after treatment for Hodgkin lymphoma.

Ng AK.

Curr Hematol Malig Rep. 2008 Jul;3(3):119-25. doi: 10.1007/s11899-008-0018-6. Review.

PMID:
20425456
8.

Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training.

Yu AF, Jones LW.

Future Cardiol. 2015 Jul;11(4):441-52. doi: 10.2217/fca.15.29. Epub 2015 Aug 3. Review.

9.

Appropriate surveillance for late complications in patients in remission from Hodgkin lymphoma.

Darrington DL, Vose JM.

Curr Hematol Malig Rep. 2012 Sep;7(3):200-7. doi: 10.1007/s11899-012-0128-z. Review.

PMID:
22743837

Supplemental Content

Support Center